3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Recurrence
1
Lymphoma, T-Cell, Peripheral
1
Hodgkin Disease
1
Interventions
pembrolizumab
514
Specimen Handling
382
Carboplatin
372
Magnetic Resonance Spectroscopy
333
Cisplatin
327
Nivolumab
303
Cyclophosphamide
295
Radiotherapy
255
Paclitaxel
252
Biopsy
235
Gemcitabine
231
Bevacizumab
212
Dexamethasone
167
durvalumab
162
Oxaliplatin
160
Capecitabine
155
Rituximab
152
Fluorouracil
148
venetoclax
143
Docetaxel
143
atezolizumab
141
Drug Therapy
140
Etoposide
139
Doxorubicin
131
Ipilimumab
126
Radiosurgery
118
Prednisone
117
Lenalidomide
117
Leucovorin
111
fludarabine
109
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
AFM13
×
1 year
×
Clear all
NCT05883449
2025-08-20
LuminICE-203
Affimed GmbH
Phase 2
Terminated
25 enrolled
21 charts